Search
Displaying all 9 results
Roflumilast
go.drugbank.com/drugs/DB01656
ApprovedInvestigational
Roflumilast is a highly selective phosphodiesterase-4 (PDE4) inhibitor. PDE4 is a major cyclic-3',5′-adenosinemonophosphate (cyclic AMP, cAMP)-metabolizing enzyme expressed on nearly all immune and pro-inflammatory cells, in addition to structural cells like those of the smooth muscle or epithelium. The resultant in...
Apremilast
go.drugbank.com/drugs/DB05676ApprovedInvestigationalIt belongs to the same drug class as [Roflumilast] and [Crisaborole].[A181244,L7495] Initially approved in 2014, it is marketed by Celgene.
Exacerbation of COPD
go.drugbank.com/conditions/DBCOND0046788Mild Atopic dermatitis
go.drugbank.com/conditions/DBCOND0025273Piclamilast
go.drugbank.com/drugs/DB01791ExperimentalThe structure for piclamilast was first elucidated in a 1995 European patent application and exhibits the structural functionalities of cilomilast and roflumilast.
Moderate Atopic dermatitis
go.drugbank.com/conditions/DBCOND0025271Plaque Psoriasis
go.drugbank.com/conditions/DBCOND0029615Drugs: Apremilast · Betamethasone · Calcipotriol · Desoximetasone · Etanercept · Flumethasone +7 moreSeborrheic Dermatitis
go.drugbank.com/conditions/DBCOND0036095Atopic Dermatitis
go.drugbank.com/conditions/DBCOND0028414